EGFR and neoplasm: Early-stage tumors were enriched in pro-inflammatory microglia, whereas late-stage tumors exhibited a predominance of anti-inflammatory macrophages and myeloid-derived suppressor cells (MDSCs), correlating with BBB disruption and EGFR+ tumor expansion [26].